Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.

Fong RH, Banik SS, Mattia K, Barnes T, Tucker D, Liss N, Lu K, Selvarajah S, Srinivasan S, Mabila M, Miller A, Muench MO, Michault A, Rucker JB, Paes C, Simmons G, Kahle KM, Doranz BJ.

J Virol. 2014 Dec;88(24):14364-79. doi: 10.1128/JVI.01943-14. Epub 2014 Oct 1.

2.

Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors.

Sulli C, Banik SS, Schilling J, Moser A, Xiang X, Payne R, Wanless A, Willis SH, Paes C, Rucker JB, Doranz BJ.

J Virol. 2013 Oct;87(19):10679-86. doi: 10.1128/JVI.01190-13. Epub 2013 Jul 24.

3.

Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes.

Lamorte L, Titolo S, Lemke CT, Goudreau N, Mercier JF, Wardrop E, Shah VB, von Schwedler UK, Langelier C, Banik SS, Aiken C, Sundquist WI, Mason SW.

Antimicrob Agents Chemother. 2013 Oct;57(10):4622-31. doi: 10.1128/AAC.00985-13. Epub 2013 Jul 1.

4.

Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.

Lemke CT, Titolo S, von Schwedler U, Goudreau N, Mercier JF, Wardrop E, Faucher AM, Coulombe R, Banik SS, Fader L, Gagnon A, Kawai SH, Rancourt J, Tremblay M, Yoakim C, Simoneau B, Archambault J, Sundquist WI, Mason SW.

J Virol. 2012 Jun;86(12):6643-55. doi: 10.1128/JVI.00493-12. Epub 2012 Apr 11.

5.

Blood vessels engineered from human cells.

Poh M, Boyer M, Solan A, Dahl SL, Pedrotty D, Banik SS, McKee JA, Klinger RY, Counter CM, Niklason LE.

Lancet. 2005 Jun 18-24;365(9477):2122-4.

PMID:
15964449
6.

Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR.

Banik SS, Counter CM.

J Biol Chem. 2004 Dec 10;279(50):51745-8. Epub 2004 Sep 20.

7.

Human arteries engineered in vitro.

McKee JA, Banik SS, Boyer MJ, Hamad NM, Lawson JH, Niklason LE, Counter CM.

EMBO Rep. 2003 Jun;4(6):633-8.

8.
9.

C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity.

Banik SS, Guo C, Smith AC, Margolis SS, Richardson DA, Tirado CA, Counter CM.

Mol Cell Biol. 2002 Sep;22(17):6234-46.

10.

The nucleolar localization domain of the catalytic subunit of human telomerase.

Etheridge KT, Banik SS, Armbruster BN, Zhu Y, Terns RM, Terns MP, Counter CM.

J Biol Chem. 2002 Jul 5;277(27):24764-70. Epub 2002 Apr 15.

11.

N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo.

Armbruster BN, Banik SS, Guo C, Smith AC, Counter CM.

Mol Cell Biol. 2001 Nov;21(22):7775-86.

Supplemental Content

Loading ...
Support Center